ClinicalTrials.gg
Drug

Vidutolimod clinical trials

Also written CMP-001 and CYT 003.

studies test it
15
open now
0
in phase 3
0
first study started
2012

How each study uses vidutolimod is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

vidutolimod
4
VLP-encapsulated TLR9 Agonist CMP-001
2

Development codes

CMP-001
12
CYT 003
4
ARB-1598
2

Studies by the year they started

15 studies that test it; most in 2021 (6)

Studies that test vidutolimod, by start year
YearStudies
20121
20141
20161
20171
20183
20201
20216
20231

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
11

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 7

Regeneron Pharmaceuticals (6) · Cytos Biotechnology AG (2) · National Cancer Institute (NCI) (1) · Centre Hospitalier Universitaire Vaudois (1) · Diwakar Davar (1) · Sheba Medical Center (1) · Emory University (1) · University of Southern California (1)

Often tested with

Tested in the same studies.

Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949 (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test vidutolimod.

Studies

Open first, then newest update. How each study uses vidutolimod is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 15

Given beside what is tested · 5 — vidutolimod is usual care or a partner of the new treatment

Codes

What other systems call vidutolimod · ClinicalTrials.gg INT016294

  • UNII (FDA) D68OW5RS98VIDUTOLIMODOne source FDA
  • NCI Thesaurus C175875VidutolimodOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.